NET PROFIT (x1000 EUR)
EMPLOYEES
Faaborg Pharma A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
273
|
272
|
5 |
| Total assets |
2,449
|
2,463
|
1,970 |
| Current assets |
1,605
|
1,495
|
1,144 |
| Current liabilities |
299
|
1,269
|
1,132 |
| Equity capital |
1,073
|
858
|
649 |
| - share capital |
134
|
134
|
134 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
43.8%
|
34.8%
|
32.9% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
536.8%
|
117.8%
|
101.1% |
| Return on equity (ROE) |
25.4%
|
31.7%
|
0.8% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.